Active
SME

Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals Ltd IPO Details

Listing Date

21 May 2025

Bid Price

₹96 - ₹101

Lot Size

600 Shares

Minimum Investment

₹1,21,200 / 2 Lots

Issue Size

₹29.75 Cr

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

14th May

tick

Offer End Date

16th May

tick

Allotment Date

19th May

tick

Refund Initiation

20th May

tick

Demat Transfer

20th May

tick

Listing Date

21st May

About Accretion Pharmaceuticals Ltd IPO

Accretion Pharmaceuticals Limited, incorporated in 2012, is a growing pharmaceutical company primarily engaged in the manufacturing and marketing of a wide range of healthcare products. Its offerings include tablets, capsules, oral liquids, and various external preparations such as ointments, creams, gels, lotions, medicated shampoos, mouthwash, and dusting powders, as well as oral powders like sachets and dry syrups. The company caters to both direct sales and contract manufacturing clients, operating majorly on a principal-to-principal business model. With ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018 certifications, Accretion Pharmaceuticals demonstrates a strong commitment to quality and regulatory compliance.
 

The company’s state-of-the-art manufacturing unit is situated in Sanand, Ahmedabad, Gujarat. Accretion Pharmaceuticals has established a robust presence in the domestic market while also extending its footprint globally, serving clients in over 20 countries across Africa, Southeast Asia, and the Middle East. Backed by an experienced board and a skilled management team, the company continues to focus on innovation, strategic partnerships, and regulatory excellence, positioning itself as a reliable player in the pharmaceutical manufacturing space.

Accretion Pharmaceuticals Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 100% 73.14%
Public Group 0% 26.86%

Accretion Pharmaceuticals Ltd IPO Reservation

QIB Shares Offered 3,52,800 (11.98%)
NII (HNI) Shares Offered 12,22,800 (41.51%)
Retail Shares Offered 12,22,800 (41.51%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 29,46,000
Total Shares With Anchor Investor 29,46,000

Accretion Pharmaceuticals Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 1,200 ₹1,21,200
Retail (Max) 2 1,200 ₹1,21,200
S HNI (Min) 3 1,800 ₹1,81,800
S HNI (Max) 16 9,600 ₹9,69,600
B HNI (MIN) 17 10,200 ₹10,30,200

Accretion Pharmaceuticals Ltd IPO Anchor Portion Size

Shares Offered 2,11,200
Anchor Investment Details 2.13312

Accretion Pharmaceuticals Ltd IPO registrar

KFin Techologies Ltd
Phone Number +91-40-6716 2222/
Email Id apl.ipo@kfintech.com
Website www.kfintech.com

Accretion Pharmaceuticals Ltd IPO Lead Manager

1. Jawa Capital Services Pvt Ltd

Accretion Pharmaceuticals Ltd Financial Information

March 31, 2025 March 31, 2024 March 31,
Net Worth ₹15.29 Cr ₹5.49 Cr ₹ Cr
Reserves and Surplus ₹7.12 Cr ₹1.49 Cr ₹ Cr
Total Borrowing ₹14.1 Cr ₹13.48 Cr ₹ Cr

Accretion Pharmaceuticals Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 3,52,800 17,19,600 4.8742
Non Institutional Investors (NIIs) 12,22,800 53,91,600 4.4092
Retail Individual Investors (RIIs) 12,22,800 1,28,95,200 10.5456
Total 27,34,800 2,00,06,400 7.3155

Strength of Accretion Pharmaceuticals Ltd

  • Experienced Promoters and Management Team.
  • Consistently supplying quality products to our valued customers in time.
  • Continually improving the quality standards by implementing process control and prevention techniques.
  • Long-standing relationship with clients and suppliers.
  • Quality standards.
  • Legacy Business Process & Management.
  • Strong and experienced R&D team.

Risks Involved

  • A significant portion of its revenue is derived from exports, and any decline in export profitability may adversely impact its overall financial performance.
  • The Company operates in pharmaceutical sector, which is extensively regulated, any failures on the company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.
  • Its manufacturing units are subject to periodic inspections and audits by regulatory authorities and clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.
  • The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.
  • The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.
  • The company generate a significant percentage of its revenue from few clients. The loss of any one or more of the company major clients would have a material adverse effect on its business operations and profitability.
  • Its inability to accurately forecast demand for the company products or manage its inventory or working capital requirements may have an adverse effect on the company business, results of operations and financial condition.
  • There was a Criminal litigation against its promoters cum directors and the company is not sure the same shall not be refiled by the concerned authority. In the event it is refiled, the interest of the promoters may divert from the business of the Company, which may adversely affect the business of the Company.
  • Its business operations are working capital intensive, and any inability to meet the company working capital requirements may adversely impact its financial condition and growth prospects.
  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Accretion Pharmaceuticals IPO

  • India holds a significant position in the global pharmaceuticals sector.

  • Key segments include: generic medicines, OTC drugs, bulk drugs, vaccines, biosimilars, biologics, and contract research & manufacturing.

  • India is a global leader in vaccine production, particularly for DPT, BCG, and Measles vaccines.

  • The country is the world’s largest supplier of generic medicines, contributing 20% of global volume.

  • It also leads globally in vaccine manufacturing.

  • India hosts the highest number of US-FDA approved pharmaceutical plants outside the US.

  • The nation is home to over 3,000 pharmaceutical companies and has more than 10,500 manufacturing units.

  • It benefits from a vast pool of highly skilled professionals.

  • The Indian pharmaceutical industry is currently valued at $50 billion.

  • It is projected to grow to $65 billion by 2024 and $130 billion by 2030.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Accretion Pharmaceuticals IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Striders Impex Limited IPO
Bidding Period
26th Feb 2026 - 3rd Mar 2026
Price Range
₹71.0 - 72.0
IPO Size
₹36,29,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 79.0
IPO Size
₹1,65,00,00,000
MANILAM INDUSTRIES INDIA LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹65.0 - 69.0
IPO Size
₹40,00,00,000
FRACTAL INDUSTRIES LIMITED IPO
Bidding Period
16th Feb 2026 - 2nd Feb 2026
Price Range
₹205.0 - 216.0
IPO Size
₹49,00,00,000
MARUSHIKA TECHNOLOGY LIMITED IPO
Bidding Period
12th Feb 2026 - 2nd Feb 2026
Price Range
₹111.0 - 117.0
IPO Size
₹27,00,00,000
FRACTAL ANALYTICS LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹857.0 - 900.0
IPO Size
₹28,34,00,00,000
AYE FINANCE LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹122.0 - 129.0
IPO Size
₹10,10,00,00,000
BIOPOL CHEMICALS LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹102.0 - 108.0
IPO Size
₹31,00,00,000
PAN HR SOLUTION LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹74.0 - 78.0
IPO Size
₹17,00,00,000
NFP SAMPOORNA FOODS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
BRANDMAN RETAIL LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹167.0 - 176.0
IPO Size
₹86,00,00,000
GROVER JEWELLS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹83.0 - 88.0
IPO Size
₹34,00,00,000
C K K RETAIL MART LIMITED IPO
Bidding Period
30th Jan 2026 - 2nd Feb 2026
Price Range
₹155.0 - 163.0
IPO Size
₹88,00,00,000
ACCRETION NUTRAVEDA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹122.0 - 129.0
IPO Size
₹25,00,00,000
MSAFE EQUIPMENTS LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹116.0 - 123.0
IPO Size
₹66,00,00,000
KANISHK ALUMINIUM INDIA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹73.0 - 73.0
IPO Size
₹29,00,00,000
KASTURI METAL COMPOSITE LIMITED IPO
Bidding Period
27th Jan 2026 - 1st Jan 2026
Price Range
₹61.0 - 64.0
IPO Size
₹18,00,00,000
HANNAH JOSEPH HOSPITAL LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹67.0 - 70.0
IPO Size
₹42,00,00,000
SHAYONA ENGINEERING LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹140.0 - 144.0
IPO Size
₹15,00,00,000
KRM AYURVEDA LIMITED IPO
Bidding Period
21st Jan 2026 - 1st Jan 2026
Price Range
₹128.0 - 135.0
IPO Size
₹77,00,00,000
SHADOWFAX TECHNOLOGIES LIMITED IPO
Bidding Period
20th Jan 2026 - 1st Jan 2026
Price Range
₹118.0 - 124.0
IPO Size
₹19,07,00,00,000
  • All
  • MainBoard
  • SME
MARUSHIKA TECHNOLOGY LIMITED IPO
Issue Prize
117.00
Listing Day Close
114.00(-2.56%)
FRACTAL ANALYTICS LIMITED IPO
Issue Prize
900.00
Listing Day Close
847.40(-5.89%)
AYE FINANCE LIMITED IPO
Issue Prize
129.00
Listing Day Close
128.90(0.00%)
BIOPOL CHEMICALS LIMITED IPO
Issue Prize
108.00
Listing Day Close
105.50(-1.85%)
PAN HR SOLUTION LIMITED IPO
Issue Prize
78.00
Listing Day Close
78.01(0.00%)
BRANDMAN RETAIL LIMITED IPO
Issue Prize
176.00
Listing Day Close
192.15(9.09%)
GROVER JEWELLS LIMITED IPO
Issue Prize
88.00
Listing Day Close
100.80(14.77%)
C K K RETAIL MART LIMITED IPO
Issue Prize
163.00
Listing Day Close
171.15(4.91%)
ACCRETION NUTRAVEDA LIMITED IPO
Issue Prize
129.00
Listing Day Close
191.20(48.06%)
MSAFE EQUIPMENTS LIMITED IPO
Issue Prize
123.00
Listing Day Close
150.30(21.95%)
KANISHK ALUMINIUM INDIA LIMITED IPO
Issue Prize
73.00
Listing Day Close
55.48(-24.66%)
KASTURI METAL COMPOSITE LIMITED IPO
Issue Prize
64.00
Listing Day Close
63.16(-1.56%)
HANNAH JOSEPH HOSPITAL LIMITED IPO
Issue Prize
70.00
Listing Day Close
68.25(-2.86%)
SHAYONA ENGINEERING LIMITED IPO
Issue Prize
144.00
Listing Day Close
151.00(4.86%)
KRM AYURVEDA LIMITED IPO
Issue Prize
135.00
Listing Day Close
180.70(34.07%)
SHADOWFAX TECHNOLOGIES LIMITED IPO
Issue Prize
124.00
Listing Day Close
109.90(-11.29%)
DIGILOGIC SYSTEMS LIMITED IPO
Issue Prize
104.00
Listing Day Close
79.05(-24.04%)
ARITAS VINYL LIMITED IPO
Issue Prize
47.00
Listing Day Close
44.65(-4.26%)
ARMOUR SECURITY INDIA LIMITED IPO
Issue Prize
57.00
Listing Day Close
43.35(-24.56%)
AM
AMAGI MEDIA LABS LIMITED IPO
Issue Prize
361.00
Listing Day Close
348.00(-3.60%)

Frequently Asked Questions

What is Accretion Pharmaceuticals Ltd IPO?

Answer Field

Accretion Pharmaceuticals Ltd IPO is a SME IPO of 29,46,000 equity shares of a face value of ₹10 aggregating up to ₹29.75 Crores. The issue is priced at ₹96 to ₹101 per share. The minimum order quantity is 600 Shares. The IPO opens on May 14, 2025, and closes on May 16, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Accretion Pharmaceuticals Ltd IPO will open?

Answer Field

The Accretion Pharmaceuticals Ltd IPO opens on May 14, 2025 and closes on May 16, 2025.

What is the lot size of Accretion Pharmaceuticals Ltd?

Answer Field

Accretion Pharmaceuticals Ltd lot size is 600 shares, and the minimum amount required is ₹1,21,200.

How to apply for Accretion Pharmaceuticals Ltd IPO?

Answer Field

You can apply in Accretion Pharmaceuticals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Accretion Pharmaceuticals Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Accretion Pharmaceuticals Ltd IPO will be done on May 19, 2025, and the allotted shares will be credited to your demat account by May 20, 2025.

When is Accretion Pharmaceuticals Ltd IPO listing date?

Answer Field

The Accretion Pharmaceuticals Ltd listing date is May 21, 2025.

Who is the registrar of Accretion Pharmaceuticals Ltd IPO?

Answer Field

The registrar of Accretion Pharmaceuticals Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Jawa Capital Services Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Accretion Pharmaceuticals Ltd IPO?

Answer Field

The fresh issue size is ₹29.75 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Accretion Pharmaceuticals Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 600 shares and ₹1,21,200 amount.

How can I approve the UPI mandate request for Accretion Pharmaceuticals Ltd IPO?

Answer Field

To apply for Accretion Pharmaceuticals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Accretion Pharmaceuticals Ltd?

Answer Field

The price of each Accretion Pharmaceuticals Ltd share will be ranging in between ₹96 to ₹101 per share.

What is the cut-off time for the UPI mandate for Accretion Pharmaceuticals Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, May 16, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|